This is why many patients seek professional hair restoration treatments to strengthen hair follicles and improve scalp health while continuing their weight loss journey
Levi Garraway, MD, PhD, Roches Chief Medical Officer and Head of Global Product Development, stated: As the only anti-CD20 to demonstrate a complete renal response benefit in a randomized phase III study of lupus nephritis, Gazyva/Gazyvaro has the potential to address an important unmet need for many people with this disease. The recommendation is supported by strong data from the Phase II NOBILITY and Phase III REGENCY studies, where nearly 46.4% of patients on Gazyva/Gazyvaro plus standard therapy achieved a complete renal response, compared to 33.1% on standard therapy alone marking a significant stride toward improved disease control and reduced corticosteroid use
doi: 10.4103/tcmj.tcmj_290_20
The most beneficial therapeutic approach to treating uncontrolled painful DPN that does not respond to monotherapy is combination therapy, 8% capsaicin patch, or SCS
Heres What Employers Should Know The FTC has announced a rule that bans noncompetes and clauses that have a similar effect
N.GerguesM
